New York Times Health  


F.D.A.’s Approval of a Drug for Autism Upends Review Process

[unable to retrieve full-text content]The agency expanded use of an old drug as a treatment for some ...View More

F.D.A.’s Approval of a Drug for Autism Upends Review Process

[unable to retrieve full-text content]The agency expanded use of an old drug as a treatment for some ...View More

Harvard Dean Was Paid $150,000 as an Expert Witness in Tylenol Lawsuits

[unable to retrieve full-text content]The Trump administration has cited Dr. Andrea Baccarelli’s exp ...View More

Harvard Dean Was Paid $150,000 as an Expert Witness in Tylenol Lawsuits

[unable to retrieve full-text content]The Trump administration has cited Dr. Andrea Baccarelli’s exp ...View More

Judge Orders N.I.H. to Restore Suspended Research Grants at U.C.L.A.

[unable to retrieve full-text content]The ruling is a preliminary injunction in a lawsuit over the T ...View More

Judge Orders N.I.H. to Restore Suspended Research Grants at U.C.L.A.

[unable to retrieve full-text content]The ruling is a preliminary injunction in a lawsuit over the T ...View More

For Trump, Who Has ‘Strong Feelings’ About Autism, the Issue Is Personal

[unable to retrieve full-text content]The president delivered impassioned — if scientifically dubiou ...View More

For Trump, Who Has ‘Strong Feelings’ About Autism, the Issue Is Personal

[unable to retrieve full-text content]The president delivered impassioned — if scientifically dubiou ...View More

Trump Issues Warning Based on Unproven Link Between Tylenol and Autism

[unable to retrieve full-text content]Top U.S. health officials urged pregnant women not to use acet ...View More

Kenvue, the Company Behind Tylenol, Tries to Navigate Its Latest Crisis

[unable to retrieve full-text content]Kenvue, a two-year-old spinoff from Johnson & Johnson, is conf ...View More

  About

Omnixia News is your intelligent news aggregator, delivering real-time, curated headlines from trusted global sources. Stay informed with personalized updates on tech, business, entertainment, and more — all in one place..